Find relevant case studies.
Select an Activa Product and refine your search by clicking on Condition and/or Publication source.
Know what you're looking for? Use the search facility to find a particular paper...
|Title||Actico - Actively targeting Lymphoedema: Case Studies||Download File|
|Author||A Williams, M Boyle|
|Publication||Internal by Activa Healthcare, October 2005|
|Key Points||5 Case Studies ranging from 15 yr old with lymphagiectasia to 64 yr old with chronic oedema.|
|Title||Leg Ulcer Pain Relief Prior to Punch Biopsy Treatment||Download File|
|Publication||Meeting the challenges of Wound Pain Activa publication Oct 05; pages 29-30|
|Key Points||Painful sloughy ulcer, healing achieved with Actiformcool under Actico inelastic bandages|
|Title||Removal of Slough, Exudate Control and Stimulation of a Healthy Wound Bed with ActiFormCool - A Case Study||Download File|
|Author||Margaret Armitage Vascular Nurse Specialist|
|Publication||Internal Publication by Activa Healthcare Ltd to accompany Road shows - Oct '05|
|Key Points||Patient with peripheral arterial occlusive disease. Angioplasty performed to increase blood flow. 6 weeks post surgery wound had increased in size. Wound began healing once Actiformcool used.|
|Title||Local infected wounds - from evidence to algorithm for the therapy - with regard to polyhexanide and silver||Download File|
|Publication||L & R literature|
|Key Points||19 patients with ulcers/multipathogenic wounds Staphylococcus streptococcus comparison with Povidone. Iodine: topical antibiotics: honey: silver. All antimicrobials -14 -21 day use; changed 1 -3 days|
|Title||Debrisoft Patient Leaflet||Download File|
|Key Points||Debrisoft explained|
The Debrisoft monafilament debridement pad for use in acute or chronic wounds
Medical technology guidance
National Institute for Health and Care Excellence (NICE)
New NICE Guidance recommends the use of Debrisoft as part of the management of acute or chronic wounds in community settings. According to NICE, hundreds of thousands of patients with wounds requiring debridement could benefit from Debrisoft. Using Debrisoft on these patients could save the NHS in the region of £15 million annually.
This information is not intended as a substitute for the advice of a health care professional. Consumers should rely on the judgement of a health care professional for specific conditions.
Activa is a Registered Trademark of Activa Healthcare Ltd. Lycra and Tactel Micro are Registered Trademarks of DuPont.
Registered in England No. 3631028 VAT No. 716473038